首页/行业动态/论文详情

黄芪多糖的上下文依赖性免疫调节:结构决定因素、结构-活性关系、机制和应用:综述

Context-dependent immunomodulation by Astragalus polysaccharides: Structural determinants, structure-activity relationships, mechanisms, and applications: A review.

科研进展PubMed 论文(药材)机译
  • 期刊International journal of biological macromolecules(Int J Biol Macromol)
  • 发表时间2026-10-16
  • 作者Wang M, Li Y, Xu H, Xu B, Qu X, Zhao J, Yang D, Liang Z
  • 卷期页码154888
  • 文献类型Review
  • DOI10.1016/j.ijbiomac.2026.154888
  • PMID42887747

摘要机译

黄芪多糖(APS)主要来源于黄芪和黄芪,作为植物源性免疫调节大分子受到广泛关注。越来越多的证据表明,APS介导的免疫调节是上下文依赖性的,而不是单向的。

原料特性、加工方法、提取程序、分级和纯化可以生成具有不同结构特征的APS级分,包括分子量分布、单糖组成、糖苷键、支链模式、链构象、溶解度和聚集行为。

该综述总结了APS结构表征、结构-活性关系、免疫调节效应、作用机制和免疫相关应用的最新进展。在免疫抑制条件下,APS可能有助于恢复受损的免疫防御,而在免疫过度激活期间,APS可能抑制过度炎症反应并支持免疫稳态。

从机制上讲,APS可能调节先天和适应性免疫反应、肠道微生物组成和代谢物产生、粘膜屏障功能和肠道器官通讯。

Toll样受体4相关核因子-κB和丝裂原活化蛋白激酶途径是最常报道的机制,而核因子红系2相关因子2/血红素加氧酶-1信号传导、调节NOD样受体家族pyrin结构域含3炎症小体、白细胞介素-22/信号转导和转录激活因子3信号传导以及微生物群介导的途径可能在特定环境中做出贡献。

此外,基于APS的干预措施已被研究用于支持性临床护理、疫苗佐剂、兽医用途、功能性食品、免疫支持产品以及药物或局部制剂。

通过将结构变异与免疫效应、机制途径和应用环境联系起来,该综述为APS的结构标准化、质量控制、活性优化和免疫相关产品开发提供了基础。

展开英文摘要原文

Astragalus polysaccharides (APS), derived mainly from Astragalus membranaceus (Fisch.) Bunge and Astragalus membranaceus var. mongholicus (Bunge) P. K. Hsiao, have attracted considerable attention as plant-derived immunomodulatory macromolecules. Accumulating evidence suggests that APS-mediated immunomodulation is context-dependent rather than unidirectional. Raw-material characteristics, processing methods, extraction procedures, fractionation, and purification can generate APS fractions with different structural characteristics, including molecular weight distribution, monosaccharide composition, glycosidic linkages, branching patterns, chain conformation, solubility, and aggregation behavior. This review summarizes recent progress in APS structural characterization, structure-activity relationships, immunomodulatory effects, mechanisms of action, and immune-related applications. Under immunosuppressive conditions, APS may help restore impaired immune defenses, whereas during immune hyperactivation, APS may suppress excessive inflammatory responses and support immune homeostasis. Mechanistically, APS may modulate innate and adaptive immune responses, gut microbial composition and metabolite production, mucosal barrier function, and gut-organ communication. Toll-like receptor 4-associated nuclear factor-κB and mitogen-activated protein kinase pathways are among the most frequently reported mechanisms, whereas nuclear factor erythroid 2-related factor 2/heme oxygenase-1 signaling, regulation of the NOD-like receptor family pyrin domain-containing 3 inflammasome, interleukin-22/signal transducer and activator of transcription 3 signaling, and microbiota-mediated pathways may contribute in specific settings. In addition, APS-based interventions have been investigated for supportive clinical care, vaccine adjuvants, veterinary use, functional foods, immune-support products, and pharmaceutical or topical formulations. By linking structural variation to immune effects, mechanistic pathways, and application contexts, this review provides a basis for the structural standardization of APS, quality control, activity optimization, and immune-related product development.

相关物质

PubMed 原文 ↗DOI 入口 ↗

本页由系统自动抓取 PubMed 元数据生成;标题与摘要版权归原作者与期刊所有;机译内容仅供参考,请以英文原文为准;收录不代表本站观点,亦不作为用药或医疗建议。